PECAM-1: Conflicts of interest in inflammation
Open accessThe DOI matches its Crossref record; 109 of the 109 references it cites were found in a registry or an index.
Abstract
Platelet endothelial cell adhesion molecule-1 (PECAM-1, CD31) is a cell adhesion and signaling receptor that is expressed on hematopoietic and endothelial cells. PECAM-1 is vital to the regulation of inflammatory responses, as it has been shown to serve a variety of pro-inflammatory and anti-inflammatory functions. Pro-inflammatory functions of PECAM-1 include the facilitation of leukocyte transendothelial migration and the transduction of mechanical signals in endothelial cells emanating from fluid shear stress. Anti-inflammatory functions include the dampening of leukocyte activation, suppression of pro-inflammatory cytokine production, and the maintenance of vascular barrier integrity. Although PECAM-1 has been well-characterized and studied, the mechanisms through which PECAM-1 regulates these seemingly opposing functions, and how they influence each other, are still not completely understood. The purpose of this review, therefore, is to provide an overview of the pro- and anti-inflammatory functions of PECAM-1 with special attention paid to mechanistic insights that have thus far been revealed in the literature in hopes of gaining a clearer picture of how these opposing functions might be integrated in a temporal and spatial manner on the whole organism level. A better understanding of how inflammatory responses are regulated should enable the development of new therapeutics that can be used in the treatment of acute and chronic inflammatory disorders.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Chemokines and leukocyte traffic
Baggiolini, M. (1998) · Nature · doi:10.1038/33340 · Cited by 2,709 · cited 1×
“Chemokine gradients serve to direct leukocytes to their destination by activating integrins on the leukocyte surface and by promoting actin cycling and polymerization events at localized sites within the cell (Baggiolini 1998).”
BackgroundA mechanosensory complex that mediates the endothelial cell response to fluid shear stress
Tzima, E., Irani-Tehrani, M., Kiosses, W. B., Dejana, E., Schultz, D. A., Engelhardt, B., Cao, G., DeLisser, H., & Schwartz, M. A. (2005) · Nature · doi:10.1038/nature03952 · Cited by 1,711 · cited 15×
“This likely has implications for atherosclerotic development in areas of the vasculature exposed to disturbed shear stress as PECAM-1 can activate the proinflammatory transcription factor NF-κB downstream of mechanical activation (Tzima et al. 2005).”
BackgroundInfluentialTakeda, K., Clausen, B. E., Kaisho, T., Tsujimura, T., Terada, N., Förster, I., & Akira, S. (1999) · Immunity · doi:10.1016/s1074-7613(00)80005-9 · Cited by 1,220 · cited 1×
“…during inflammation (Alonzi et al. 2001), and although it can mediate transcription of both pro- and antiinflammatory genes, studies in cell-type specific knockout mice suggest that its antiinflammatory effects might predominate in models of inflammation (Takeda et al. 1999; Kano et al. 2003).”
BackgroundPECAM-1 is required for transendothelial migration of leukocytes.
Muller, W. A., Weigl, S. A., Deng, X., & Phillips, D. M. (1993) · The Journal of experimental medicine · doi:10.1084/jem.178.2.449 · Cited by 1,152 · cited 6×
“N IH -PA Author M anuscript N IH -PA Author M anuscript N IH -PA Author M anuscript N IH -PA Author M anuscript N IH -PA Author M anuscript N IH -PA Author M anuscript Table 1 Pro-inflammatory functions of PECAM-1 Inflammatory Model Results Mousestrain References Neutrophil chemotaxis in Zigmund chambers toward IL-8,…”
BackgroundInfluentialPECAM-1 (CD31) Cloning and Relation to Adhesion Molecules of the Immunoglobulin Gene Superfamily
Newman, P. J., Berndt, M. C., Gorski, J., White, G. C., Lyman, S., Paddock, C., & Muller, W. A. (1990) · Science · doi:10.1126/science.1690453 · Cited by 950 · cited 3×
“PECAM-1 is also highly expressed on endothelial cells, where it is a major constituent of the endothelial cell intercellular junction in confluent vascular beds (Muller et al. 1989; Albelda et al. 1990; Newman et al. 1990; Newman 1997).”
BackgroundSelf-citationAnti-inflammatory lipid mediators and insights into the resolution of inflammation
Lawrence, T., Willoughby, D. A., & Gilroy, D. W. (2002) · Nature Reviews Immunology · doi:10.1038/nri915 · Cited by 862 · cited 1×
“These cardinal signs are largely the result of two main components of inflammatory responses: (1) increased vascular permeability and (2) the emigration, accumulation, and activation of leukocytes (Lawrence et al. 2002).”
BackgroundSphingosine 1-phosphate and its receptors: an autocrine and paracrine network
Rosen, H., & Goetzl, E. J. (2005) · Nature Reviews Immunology · doi:10.1038/nri1650 · Cited by 694 · cited 7×
“Due to the importance of S1P in vascular barrier function and the ability of S1P and PECAM-1 to regulate each other, further clarity is needed to determine whether PECAM-1 can indeed promote barrier maintenance through S1P signaling.”
BackgroundInfluentialNewman, P. J. (1997) · Journal of Clinical Investigation · doi:10.1172/jci119129 · Cited by 664 · cited 2×
“It is expressed on most cells of the hematopoietic lineage including platelets, monocytes, neutrophils, and lymphocyte subsets (Newman 1997; Newman 1999; Newman and Newman 2003).”
BackgroundSelf-citationPECAM-1: A Multi-Functional Molecule in Inflammation and Vascular Biology
Woodfin, A., Voisin, M.-B., & Nourshargh, S. (2007) · Arteriosclerosis, Thrombosis, and Vascular Biology · doi:10.1161/atvbaha.107.151456 · Cited by 583
Involvement of Platelet-Endothelial Cell Adhesion Molecule-1 in Neutrophil Recruitment in Vivo
Vaporciyan, A. A., DeLisser, H. M., Yan, H.-C., Mendiguren, I. I., Thom, S. R., Jones, M. L., Ward, P. A., & Albelda, S. M. (1993) · Science · doi:10.1126/science.8248808 · Cited by 458 · cited 8×
“…immune complex deposition in lungs in rats Antibody-blockade of PECAM-1 blocked accumulation of neutrophils into the alveolar compartment N/A (Vaporciyan et al. 1993) Human skin grafts transplanted into immunodeficient mice Antibody-blockade of PECAM-1 blocked accumulation of…”
BackgroundInfluential
Cited by
Endothelial functions of platelet/endothelial cell adhesion molecule-1 (CD31)
Lertkiatmongkol, P., Liao, D., Mei, H., Hu, Y., & Newman, P. J. (2016) · Current Opinion in Hematology · doi:10.1097/moh.0000000000000239 · Cited by 626
Self-citationCoon, B. G., Baeyens, N., Han, J., Budatha, M., Ross, T. D., Fang, J. S., Yun, S., Thomas, J.-L., & Schwartz, M. A. (2015) · Journal of Cell Biology · doi:10.1083/jcb.201408103 · Cited by 299
Diabetic retinopathy: Breaking the barrier
Eshaq, R. S., Aldalati, A. M. Z., Alexander, J. S., & Harris, N. R. (2017) · Pathophysiology · doi:10.1016/j.pathophys.2017.07.001 · Cited by 169
“PECAM-1 is a 130 kDa transmembrane glycoprotein that belongs to the IgG superfamily of receptors with an immunoreceptor tyrosine-like inhibitory motif (ITIM) domain [205].”
BackgroundApoptosis in capillary endothelial cells in ageing skeletal muscle
Wang, H., Listrat, A., Meunier, B., Gueugneau, M., Coudy‐Gandilhon, C., Combaret, L., Taillandier, D., Polge, C., Attaix, D., Lethias, C., et al. (2014) · Aging Cell · doi:10.1111/acel.12169 · Cited by 109
Gröger, M., Rennert, K., Giszas, B., Weiß, E., Dinger, J., Funke, H., Kiehntopf, M., Peters, F. T., Lupp, A., Bauer, M., et al. (2016) · Scientific Reports · doi:10.1038/srep21868 · Cited by 60
Metadata
- Authors
- Privratsky, J. R., Newman, D. K., & Newman, P. J.
- Venue
- Life Sciences
- Publisher
- Elsevier BV
- Published
- 2010-07
- Volume
- 87
- Issue
- 3-4
- Pages
- 69-82
- ISSN
- 0024-3205 (ISSN-L)
- OpenAlex
- W2026252047
- Cited by
- 204
- References
- 109
- FWCI
- 9.92
- Type
- journal article
- Language
- en
- Open access
- green
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.